Tag:
thymalfasin
Latest Headlines
Latest Headlines
SciClone's hep C drug fails late-stage trial
SciClone Pharmaceuticals' late-stage therapy for hepatitis C failed to hit a primary endpoint in a late-stage trial. The drug, thymalfasin, failed to register a significant response in patients who
